文献速递肝病消化道肿瘤与早癌

IL-17信号在脂肪变性肝细胞和巨噬细胞中促进酒精相关肝病肝细胞癌

IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease.
PubMed 文献 · J Hepatol · 2019-12-31

该研究利用基因敲除和药物阻断小鼠模型及人类标本,探究IL-17A/IL-17RA信号在酒精相关肝细胞癌(HCC)中的作用。结果显示,整体或髓系细胞、肝细胞特异性敲除Il-17ra可抑制酒精喂养联合二乙基亚硝胺小鼠的HCC发生,而肝星状细胞敲除无效;抗IL-12/IL-23抗体阻断IL-17A/Th17细胞可使酒精喂养小鼠HCC进展减少70%。结论提示IL-17A是促瘤细胞因子,可能成为酒精相关HCC的治疗靶点。

要点

  • 髓系细胞或肝细胞特异性敲除IL-17RA可减少酒精相关HCC发生
  • 肝细胞IL-17RA缺失减少脂肪变性和纤维化,并下调趋化因子及胆固醇合成
  • 抗IL-12/IL-23抗体阻断IL-17A/Th17使小鼠HCC进展减少70%

核心结论

  • IL-17A是促瘤细胞因子,关键调控酒精诱导的肝脂肪变性、炎症、纤维化和HCC。

研究设计与样本

  • 采用基因敲除和药物阻断方法,在小鼠模型和人类标本中表征IL-17A/IL-17RA信号在HCC发病中的作用。

主要发现

  • 整体敲除Il-17ra可抑制酒精喂养的DEN挑战Il-17ra-/-和MUP-uPA/Il-17ra-/-小鼠的HCC。
  • 髓系细胞和肝细胞特异性敲除IL-17RA均减少HCC发生,而肝星状细胞特异性敲除无此效应。
  • 酒精喂养的Il-17raΔHep小鼠肿瘤最少,伴有脂肪变性和纤维化减少。
  • 脂肪变性IL-17RA缺陷肝细胞下调Cxcl1等趋化因子,胆固醇合成途径缺陷,并上调抗氧化维生素D3。
  • 抗IL-12/IL-23抗体阻断IL-17A/Th17细胞使酒精喂养小鼠HCC进展减少70%。

临床怎么用

  • 靶向IL-17信号可能为酒精相关HCC提供新的治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Chronic alcohol consumption is a leading risk factor for the development of hepatocellular carcinoma (HCC), which is associated with a marked increase in hepatic expression of pro-inflammatory IL-17A and its receptor IL-17RA. METHODS: Genetic deletion and pharmacological blocking were used to characterize the role of IL-17A/IL-17RA signaling in the pathogenesis of HCC in mouse models and human specimens. RESULTS: We demonstrate that the global deletion of the Il-17ra gene suppressed HCC in alcohol-fed diethylnitrosamine-challenged Il-17ra-/- and major urinary protein-urokinase-type plasminogen activator/Il-17ra-/- mice compared with wild-type mice. When the cell-specific role of IL-17RA signaling was examined, the development of HCC was decreased in both alcohol-fed Il-17raΔMΦ and Il-17raΔHep mice devoid of IL-17RA in myeloid cells and hepatocytes, but not in Il-17raΔHSC mice (deficient in IL-17RA in hepatic stellate cells). Deletion of Il-17ra in myeloid cells ameliorated tumorigenesis via suppression of pro-tumorigenic/inflammatory and pro-fibrogenic responses in alcohol-fed Il-17raΔMΦ mice. Remarkably, despite a normal inflammatory response, alcohol-fed Il-17raΔHep mice developed the fewest tumors (compared with Il-17raΔMΦ mice), with reduced steatosis and fibrosis. Steatotic IL-17RA-deficient hepatocytes downregulated the expression of Cxcl1 and other chemokines, exhibited a striking defect in tumor necrosis factor (TNF)/TNF receptor 1-dependent caspase-2-SREBP1/2-DHCR7-mediated cholesterol synthesis, and upregulated the production of antioxidant vitamin D3. The pharmacological blocking of IL-17A/Th-17 cells using anti-IL-12/IL-23 antibodies suppressed the progression of HCC (by 70%) in alcohol-fed mice, indicating that targeting IL-17 signaling might provide novel strategies for the treatment of alcohol-induced HCC. CONCLUSIONS: Overall, IL-17A is a tumor-promoting cytokine, which critically regulates alcohol-induced hepatic steatosis, inflammation, fibrosis, and HCC. LAY SUMMARY: IL-17A is a tumor-promoting cytokine, which critically regulates inflammatory responses in macrophages (Kupffer cells and bone-marrow-derived monocytes) and cholesterol synthesis in steatotic hepatocytes in an experimental model of alcohol-induced HCC. Therefore, IL-17A may be a potential therapeutic target for patients with alcohol-induced HCC.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ma HY, Yamamoto G, Xu J, et al. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. J Hepatol. 2019. PMID: 31899206. doi:10.1016/j.jhep.2019.12.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。